CA Patent

CA1320132C — Dehydroepiandrosterone therapy

Assigned to City of Hope · Expires 1993-07-13 · 33y expired

What this patent protects

ABSTRACT Dehydroepiandrosterone and acceptable salts thereof are utilized for sexual disfunction therapy.

USPTO Abstract

ABSTRACT Dehydroepiandrosterone and acceptable salts thereof are utilized for sexual disfunction therapy.

Drugs covered by this patent

Intrarosa (PRASTERONE)

Patent Metadata

Patent number: CA1320132C
Jurisdiction: CA
Classification: —
Expires: 1993-07-13
Drug substance claim: No
Drug product claim: No
Assignee: City of Hope
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.